Covid-19 vaccines for children under 12 are inching closer to reality. Parents eager to protect their young ones from Covid-19 have been anticipating the availability of vaccines for some time now, and the timeline is finally becoming more defined. Pfizer is aiming to have sufficient data to request emergency use authorization for its vaccine targeting kids aged 5 to 11 by the end of September. This news is particularly reassuring for parents as they prepare for a new school year amid the ongoing surge of the delta variant.
Once the application is submitted to the FDA, approval could come swiftly—Pfizer’s adult vaccine received emergency use authorization in just three weeks. This development could potentially make around 50 million children in the U.S. eligible for vaccination, as reported by NPR. Vaccines for even younger children are expected to follow shortly thereafter.
Moderna is also on a similar trajectory, planning to seek emergency use authorization for its vaccine for kids aged 6 and older by the end of this year, with vaccines for younger children anticipated in early 2022. While adult vaccines have been available since December, both companies have conducted extensive trials segmented by age group. “We are examining varying doses for different age brackets, as younger children might require lower doses than adults,” explained Dr. Samuel Carter, a senior VP at Moderna. He noted that preliminary results have mirrored those for adults, with no safety issues reported.
As Covid-19 cases steadily rise across various regions, driven by the highly transmissible Delta variant, the urgency for child vaccinations intensifies. Over 120,000 cases in kids were reported between August 5 and August 12, comprising nearly 20% of total cases in the U.S., according to the American Academy of Pediatrics (AAP). The increase in cases among children is largely attributed to rising infection rates among unvaccinated family members, as Dr. Lisa Monroe of the AAP’s Committee on Infectious Diseases stated. Until children can be vaccinated themselves, they depend on the vaccination of adults around them.
Currently, about 70% of American adults have received at least one vaccine dose, while only around 30% of eligible children have been vaccinated. As more children return to classrooms without masks, the likelihood of infections may continue to climb. Widespread vaccination across all age groups will be essential to curb this trend.
For further insights, you can explore more about home insemination and pregnancy resources. If you’re interested in boosting fertility, check out this resource for expert guidance. For comprehensive information on pregnancy, visit this excellent resource. Also, you might find our related post on home insemination intriguing.
Search queries related to this topic include:
- Covid vaccine for kids
- Emergency use authorization for child vaccines
- Pfizer vaccine for children
- Moderna vaccine timeline
- Delta variant impact on children
In summary, Pfizer plans to apply for emergency use authorization for its Covid-19 vaccine for children aged 5 to 11 by the end of September. This move is highly anticipated by parents looking to safeguard their kids as schools reopen amidst rising infection rates, particularly with the Delta variant in circulation. Moderna is also working on its vaccine for children, with applications expected soon. The urgency for child vaccinations is underscored by the increasing case numbers among unvaccinated kids.
Leave a Reply